Micro Emerging Active

Penerimaan FDA ImmunityBio untuk terapi kanker

Narasi baru dengan cakupan terbatas — masih terbentuk.

Skor
0,2
Kecepatan
▲ 0,0
Artikel
2
Sumber
1

Linimasa Sentimen

Linimasa Peristiwa

Jun 07, 2026
ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy … Bullish
Mei 20, 2026
Why ImmunityBio Stock is Soaring Higher Today Neutral

Artikel Terkait

ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now

Yahoo Finance · Jun 07, 2026
Bearish

Why ImmunityBio Stock is Soaring Higher Today

Yahoo Finance · Mei 20, 2026
Bearish

Lini Waktu

Terakhir DiperbaruiMei 20, 2026